{"transactions":[{"id":1553794,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-04-02T19:42:50.000Z","date":"2024-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":163,"price":5.67,"value":924.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":48129,"source":{"system":"sec-edgar","filing":"0001062993-24-007839","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000106299324007839/form4.xml","form_type":"4"}},{"id":1616077,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-27T16:35:16.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":19300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests 25% on February 23, 2025, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates."}],"balance_after":19300,"derivative":{"exercise_price":7.07,"expiration_date":"2034-02-23","underlying":"Common Stock","underlying_shares":19300},"source":{"system":"sec-edgar","filing":"0001062993-24-004574","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000106299324004574/form4.xml","form_type":"4"}},{"id":1616076,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-27T16:35:16.000Z","date":"2024-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":940,"price":7.07,"value":6645.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs."}],"balance_after":48292,"source":{"system":"sec-edgar","filing":"0001062993-24-004574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000106299324004574/form4.xml","form_type":"4"}},{"id":1616075,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-27T16:35:16.000Z","date":"2024-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":2315,"price":7.07,"value":16367.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs."}],"balance_after":49232,"source":{"system":"sec-edgar","filing":"0001062993-24-004574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000106299324004574/form4.xml","form_type":"4"}},{"id":1616074,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-27T16:35:16.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":13200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") will vest in four equal annual installments beginning on February 23, 2025, subject to the Reporting Person's continuous service through the applicable vesting dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 156 shares acquired under the Company's employee stock purchase plan on July 31, 2023 and 204 shares acquired under the Company's employee stock purchase plan on January 31, 2024."}],"balance_after":51547,"source":{"system":"sec-edgar","filing":"0001062993-24-004574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000106299324004574/form4.xml","form_type":"4"}},{"id":1928565,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-04-04T18:02:42.000Z","date":"2023-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":163,"price":10.64,"value":1734.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":37987,"source":{"system":"sec-edgar","filing":"0001062993-23-008666","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000106299323008666/form4.xml","form_type":"4"}},{"id":1990548,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-27T19:19:30.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":26400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests 25% on February 23, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates."}],"balance_after":26400,"derivative":{"exercise_price":10.5,"expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":26400},"source":{"system":"sec-edgar","filing":"0001062993-23-005027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000106299323005027/form4.xml","form_type":"4"}},{"id":1990547,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-02-27T19:19:30.000Z","date":"2023-02-24","kind":"tax_withholding","acquired":false,"shares":940,"price":11.03,"value":10368.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs."}],"balance_after":38150,"source":{"system":"sec-edgar","filing":"0001062993-23-005027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000106299323005027/form4.xml","form_type":"4"}},{"id":1990546,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-02-27T19:19:30.000Z","date":"2023-02-23","kind":"tax_withholding","acquired":false,"shares":906,"price":10.5,"value":9513.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs."}],"balance_after":39090,"source":{"system":"sec-edgar","filing":"0001062993-23-005027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000106299323005027/form4.xml","form_type":"4"}},{"id":1990545,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-02-27T19:19:30.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":16800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") will vest in four equal annual installments beginning on February 23, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates."}],"balance_after":39996,"source":{"system":"sec-edgar","filing":"0001062993-23-005027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000106299323005027/form4.xml","form_type":"4"}},{"id":2311356,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-04-01T16:44:48.000Z","date":"2022-03-31","kind":"tax_withholding","acquired":false,"shares":163,"price":11.63,"value":1895.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":23196,"source":{"system":"sec-edgar","filing":"0001062993-22-009228","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000106299322009228/form4.xml","form_type":"4"}},{"id":2369198,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-28T16:24:14.000Z","date":"2022-02-24","kind":"tax_withholding","acquired":false,"shares":939,"price":11.98,"value":11249.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":23359,"source":{"system":"sec-edgar","filing":"0001062993-22-005912","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000106299322005912/form4.xml","form_type":"4"}},{"id":2372269,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-25T17:08:36.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":18600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on February 23, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates."}],"balance_after":18600,"derivative":{"exercise_price":11.75,"expiration_date":"2032-02-23","underlying":"Common Stock","underlying_shares":18600},"source":{"system":"sec-edgar","filing":"0001062993-22-005775","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000106299322005775/form4.xml","form_type":"4"}},{"id":2372268,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-25T17:08:36.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":10800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units will vest in four equal annual installments beginning on February 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting dates."}],"balance_after":24298,"source":{"system":"sec-edgar","filing":"0001062993-22-005775","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000106299322005775/form4.xml","form_type":"4"}},{"id":2761591,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-04-02T14:42:17.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":2298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units will vest in four equal annual installments beginning on March 31, 2022, subject to the Reporting Person's continuous service with the Issuer."}],"balance_after":13498,"source":{"system":"sec-edgar","filing":"0001192482-21-000298","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000119248221000298/edgar.xml","form_type":"4"}},{"id":2829951,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-26T17:24:28.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":20400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on February 24, 2022, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer."}],"balance_after":20400,"derivative":{"exercise_price":16.99,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":20400},"source":{"system":"sec-edgar","filing":"0001192482-21-000188","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000119248221000188/edgar.xml","form_type":"4"}},{"id":2829950,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-02-26T17:24:28.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":11200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units will vest in four equal annual installments beginning on February 24, 2022, subject to the Reporting Person's continuous service with the Issuer."}],"balance_after":11200,"source":{"system":"sec-edgar","filing":"0001192482-21-000188","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000119248221000188/edgar.xml","form_type":"4"}},{"id":3298932,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":92359,"kind":"person","name":"Murphy Peter C.","position":1,"cik":"0001801542","reported_name":"Murphy Peter C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-29T19:14:53.000Z","date":"2020-01-27","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on January 27, 2021, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer."}],"balance_after":60000,"derivative":{"exercise_price":15.5,"expiration_date":"2030-01-27","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001192482-20-000068","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801542/000119248220000068/edgar.xml","form_type":"4"}}]}